1.1100
+0.0600
+(5.71%)
At close: April 17 at 4:00:01 PM EDT
1.1300
+0.02
+(1.80%)
After hours: April 17 at 7:56:35 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-122,874
-122,874
-132,263
-248,208
-162,870
Investing Cash Flow
12,218
12,218
112,665
166,751
-324,023
Financing Cash Flow
99,892
99,892
85
9,207
453,129
End Cash Position
46,283
46,283
57,047
76,560
148,810
Capital Expenditure
-730
-730
-6,153
-35,566
-50,704
Issuance of Capital Stock
74,531
74,531
--
--
411,735
Free Cash Flow
-123,604
-123,604
-138,416
-283,774
-213,574
12/31/2021 - 10/1/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALLO Allogene Therapeutics, Inc.
1.4500
+3.57%
EDIT Editas Medicine, Inc.
1.2800
+0.79%
BEAM Beam Therapeutics Inc.
17.00
+2.29%
IOVA Iovance Biotherapeutics, Inc.
3.0600
-0.33%
NTLA Intellia Therapeutics, Inc.
7.23
+5.39%
VERV Verve Therapeutics, Inc.
4.5900
+1.77%
CRBU Caribou Biosciences, Inc.
0.7350
+0.26%
SGMO Sangamo Therapeutics, Inc.
0.7056
+2.96%
CHRS Coherus BioSciences, Inc.
1.1200
+10.89%
AFMD Affimed N.V.
0.7335
+1.03%